MARATTO

article · Discover Public Health

Stakeholders’ perspectives on involvement of community pharmacists in vaccine delivery services and implications for policy reform in Nigeria

20245 citationsOpen accessUniversity of Ibadan

Abstract

Abstract Vaccination has proven to be one of the most potent ways of achieving disease prevention and consequently reducing the number of global deaths due to diseases. As a result, vaccination coverage must be prioritised in public health. Community pharmacists are pitched as critical to reaching broader vaccination coverage in Nigeria due to their position as one of the most accessible healthcare professionals in the country. However, the factors affecting the involvement of these professionals as vaccine administrators have not been adequately established. This study was thus conducted as a collaborative action qualitative research via the interview of regulatory and professional stakeholders to ascertain this involvement and propose steps to be taken towards the progress of integrating the pharmacists into immunisation programmes. The study results showed that while pharmacists do not face direct restrictions when administering vaccines, they are not enabled to do so by law. Also, pharmacists’ uptake of the vaccine administrator role would benefit the Nigerian health system, and efforts are geared toward officially incorporating pharmacists. To this end, the government's support via funding and policymaking is solicited for better outcomes.

Research topics

  • Vaccine Coverage and Hesitancy
  • HIV/AIDS Impact and Responses
  • HIV, Drug Use, Sexual Risk

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s12982-024-00151-8

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.